Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-601X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials ; volume:7 ; number:5 ; day:20 ; month:8 ; year:2016 ; pages:368-377 ; date:10.2016
Translational stroke research ; 7, Heft 5 (20.8.2016), 368-377, 10.2016
- Urheber
-
Muir, Keith W.
- Beteiligte Personen und Organisationen
-
Macrae, I. Mhairi
SpringerLink (Online service)
- DOI
-
10.1007/s12975-016-0487-1
- URN
-
urn:nbn:de:1111-201611022357
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Muir, Keith W.
- Macrae, I. Mhairi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Guidelines for preclinical evaluation and clinical trials in osteoporosis
Adjustment for exploratory cut‐off selection in randomized clinical trials with survival endpoint
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Neuroimaging : clinical and physical principles
Leveraging hybrid biomarkers in clinical endpoint prediction
Informative noncompliance in endpoint trials
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Guidelines for preclinical evaluation and clinical trials in osteoporosis
Adjustment for exploratory cut‐off selection in randomized clinical trials with survival endpoint
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Neuroimaging : clinical and physical principles
Leveraging hybrid biomarkers in clinical endpoint prediction
Informative noncompliance in endpoint trials
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Guidelines for preclinical evaluation and clinical trials in osteoporosis
Adjustment for exploratory cut‐off selection in randomized clinical trials with survival endpoint
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
Neuroimaging : clinical and physical principles
Leveraging hybrid biomarkers in clinical endpoint prediction
Informative noncompliance in endpoint trials
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases